Vycor Medical (VYCO) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.85% |
| Dec 31, 2025 | -15.01% |
| Sep 30, 2025 | 15.13% |
| Jun 30, 2025 | 16.19% |
| Mar 31, 2025 | 25.27% |
| Dec 31, 2024 | 15.05% |
| Sep 30, 2024 | -18.40% |
| Jun 30, 2024 | -15.63% |
| Mar 31, 2024 | -16.75% |
| Dec 31, 2023 | 38.19% |
| Sep 30, 2023 | -18.52% |
| Jun 30, 2023 | -29.91% |
| Mar 31, 2023 | -52.90% |
| Dec 31, 2022 | 22.15% |
| Sep 30, 2022 | 23.49% |
| Jun 30, 2022 | 22.99% |
| Mar 31, 2022 | 25.09% |
| Dec 31, 2021 | 18.01% |
| Sep 30, 2021 | 15.13% |
| Jun 30, 2021 | 14.91% |
| Mar 31, 2021 | 15.24% |
| Dec 31, 2020 | 40.04% |
| Sep 30, 2020 | 15.31% |
| Jun 30, 2020 | 12.21% |
| Mar 31, 2020 | 25.59% |
| Sep 30, 2019 | 16.39% |
| Jun 30, 2019 | 16.17% |
| Mar 31, 2019 | 17.39% |
| Dec 31, 2018 | 0.91% |
| Sep 30, 2018 | 18.06% |
| Jun 30, 2018 | 21.53% |
| Mar 31, 2018 | 20.04% |
| Dec 31, 2017 | 7.69% |
| Sep 30, 2017 | 11.41% |
| Jun 30, 2017 | 14.68% |
| Mar 31, 2017 | 16.78% |
| Dec 31, 2016 | 11.12% |
| Sep 30, 2016 | 21.99% |
| Jun 30, 2016 | 30.14% |
| Mar 31, 2016 | 10.83% |
| Dec 31, 2015 | 13.64% |
| Sep 30, 2015 | -7.26% |
| Jun 30, 2015 | 0.00% |